Genmab A/S Current Assets
The Current Assets of Genmab A/S (GMAB.CO) as of Sep 26, 2026 is 1.42 B USD. In the previous year, Current Assets was 4.18 B USD — a change of -66.07% (lower).
Get this data via API
Financial Data API
Current Assets
1.42 BUSD
YoY
-66.07%
Last updated:
The Genmab A/S Current Assets history
3 Years
10 Years
25 Years
Max
| YEAR | Current Assets | YoY |
|---|---|---|
| 1.42 BUSD | -66.07% | |
| 4.18 BUSD | -17.44% | |
| 5.06 BUSD | +18.19% | |
| 4.28 BUSD | +22.91% | |
| 3.48 BUSD | +21.15% | |
| 2.88 BUSD | +34.80% | |
| 2.13 BUSD | +86.91% | |
| 1.14 BUSD | +22.04% | |
| 935.14 MUSD | +26.33% | |
| 740.23 MUSD | +31.78% | |
| 561.71 MUSD | +31.97% | |
| 425.65 MUSD | +61.17% | |
| 264.10 MUSD | +2.72% | |
| 257.10 MUSD | +15.03% | |
| 223.50 MUSD | -38.15% | |
| 361.38 MUSD | +15.13% | |
| 313.89 MUSD | +13.25% | |
| 277.16 MUSD | -51.22% | |
| 568.17 MUSD | +113.93% | |
| 265.59 MUSD | +36.33% | |
| 194.81 MUSD | +8.65% | |
| 179.31 MUSD | +9.42% | |
| 163.88 MUSD | -24.75% | |
| 217.79 MUSD | +13.23% | |
| 192.34 MUSD | -13.84% | |
| 223.24 MUSD | +4,039.51% | |
| 5.39 MUSD | — |
Genmab A/S Stock analysis
Frequently Asked Questions about Genmab A/S stock
Current Assets of Genmab A/S is 1.42 B USD in 2026.
Current Assets of Genmab A/S changed from 4.18 B USD to 1.42 B USD, representing a -66.07% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of Current Assets Genmab A/S since 2006 – with annual values, charts, and detailed analysis.
Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.
Current Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Genmab A/S historically and in real time.
Balance Sheet — Genmab A/S
All Key Metrics — Genmab A/S
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth